Smith & Nephew plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Roland Diggelmann, was filed 01 Apr 2020.
Smith & Nephew plc: what insiders have been doing
Headquartered in London, United Kingdom, Smith & Nephew plc is a listed company and traces its origins to 1856. Filings by its managers are published through RNS (LSE). Smith & Nephew plc has had no insider filing for more than a year; the last one goes back to 1 April 2020.
Since 2016, the database holds 5 purchases and 3 sales by insiders of the company.
Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 6,000 shares@ £14.24295.6% of flowThe London Stock Exchange (XLON)ISIN GB0009223206FCA-NSM:LSE20200401093004_3549145_20200424140758735Canonical exit: 30 Jun 2020 (T+90)
- 14,058.01 shares@ US$2.0193100.0% of flowUBSAISIN US83175M2052FCA-NSM:LSE20190613141206_14110139_20200326185129674_19856Canonical exit: 11 Sept 2019 (T+90)
- 20,000 shares@ £16.2491100.0% of flowXLONISIN GB0009223206FCA-NSM:LSE20190520110337_14080199_20200326185142192_13444
- 4,696 shares@ £15.845100.0% of flowXLONISIN GB0009223206FCA-NSM:LSE20190507130731_14065073_20200326185142978_24887
- 1,540 shares@ £15.3211100.0% of flowXLONISIN GB0009223206FCA-NSM:LSE20190503101121_14062462_20200326185143093_26759Canonical exit: 1 Aug 2019 (T+90)
- 4,500 shares@ £277.910692.0% of flow1) SICS 2) AQXE 3) XLONISIN GB0009223206FCA-NSM:LSE20180509172545_13635277_20200330111432015_18682Canonical exit: 7 Aug 2018 (T+90)
- 112,107 shares@ US$743.9137100.0% of flow1) ARCA 2) BATS 3) BEX 4) BYXX 5) DBAX 6) EDGA 7) EDGX 8) IEX 9) INET 10) NFSC 11) NITE 12) XDOTISIN US83175M2052FCA-NSM:LSE20180509080915_13634190_20200330111432050_19440Canonical exit: 7 Aug 2018 (T+90)
- 8,302 shares@ £13.256514.3% of flowFCA-NSM:LSE20180312121831_13563440_20200330111427646_20299-1
- 13,497 shares@ £13.256512.7% of flowFCA-NSM:LSE20180312121831_13563440_20200330111427646_20299-0
- 3,732 shares@ £13.256514.5% of flowFCA-NSM:LSE20180312121831_13563440_20200330111427646_20299-2
- 3,145 shares@ £13.256516.2% of flowFCA-NSM:LSE20180312121831_13563440_20200330111427646_20299-3
- 2,617 shares@ £13.256514.8% of flowFCA-NSM:LSE20180312121831_13563440_20200330111427646_20299-4
- 5,725 shares@ £13.256521.0% of flowFCA-NSM:LSE20180312121831_13563440_20200330111427646_20299-5
- 3,423 shares@ £13.256512.3% of flowFCA-NSM:LSE20180312121831_13563440_20200330111427646_20299-6
- 14,141 shares@ £13.014513.0% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-0
- 6,399 shares@ £13.014524.3% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-1
- 4,346 shares@ £13.014521.9% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-2
- 3,211 shares@ £13.014517.8% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-3
- 1,933 shares@ £13.014512.3% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-4
- 5,776 shares@ £13.014520.7% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-5
- 7,369 shares@ £13.014528.6% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-6
- 6,700 shares@ £13.014523.6% of flowFCA-NSM:LSE20180308132031_13560153_20200330111427774_23009-7
- 40,801 shares@ £12.9137.2% of flowFCA-NSM:LSE20180308131522_13560149_20200330111427774_23011-0
- 37,529 shares@ £12.9149.2% of flowFCA-NSM:LSE20180308131522_13560149_20200330111427774_23011-1
- 25,159 shares@ £12.9142.0% of flowFCA-NSM:LSE20180308131522_13560149_20200330111427774_23011-2
25 of 53 declarations
About Smith & Nephew plc
Smith & Nephew plc is a British company specializing in medical devices, particularly in the fields of orthopedic surgery and wound care. It is listed on the London Stock Exchange.
